July 28, 2026

Evotec SE (EVO) Stock Analysis: Exploring a 96.5% Potential Upside Despite Current Challenges

Evotec SE (EVO), a prominent player in the healthcare sector, specializes in drug discovery and development with a focus on addressing a broad spectrum of diseases. Headquartered in Hamburg, Germany,..

Brookdale Senior Living Inc. (BKD) Stock Analysis: A Closer Look at its 26.59% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a leading operator in the healthcare sector’s medical care facilities industry, presents an intriguing opportunity for investors looking to capitalize on its significant potential..

Schrodinger, Inc. (SDGR) Stock Analysis: Understanding the 34.63% Potential Upside in Health Information Services

Schrodinger, Inc. (NASDAQ: SDGR), a prominent player in the Healthcare sector, specifically within Health Information Services, provides a unique investment opportunity with its innovative approach to drug discovery and materials..

Certara, Inc. (CERT) Stock Analysis: A Healthcare Investment with Limited Upside Potential

Certara, Inc. (NASDAQ: CERT), a key player in the health information services industry, is gaining traction among investors with its innovative technology-driven services and software products. Operating within the healthcare..

Neogen Corporation (NEOG): Investor Outlook Reveals 28% Potential Upside Amid Challenging Metrics

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector, specifically within medical devices, has captured investor attention with its potential upside of 28.48%. Despite recent challenges reflected in..

ARS Pharmaceuticals (SPRY) Stock Analysis: A Potential 364% Upside in Biotech Innovator

Investors looking for compelling opportunities in the biotechnology sector may find ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) particularly intriguing. With a significant market cap of $571.99 million and a robust focus..

Amphastar Pharmaceuticals, Inc. (AMPH) Investor Outlook: Evaluating a 14.70% Potential Upside

Investors eyeing Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) may find the current market conditions intriguing, given the company’s promising 14.70% potential upside. Amphastar, a key player in the healthcare sector specializing..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Navigating Growth with Diverse Offerings in the Healthcare Sector

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), a prominent player in the healthcare sector, is carving a niche in the drug manufacturing industry with its diverse portfolio that includes generics, injectables, biosimilars,..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Unveiling a 45.60% Potential Upside in Precision Oncology

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) has been capturing attention in the biotechnology sector with its innovative approach to precision medicine oncology. With a market capitalization of $3.54 billion, the company..

Disc Medicine, Inc. (IRON) Stock Analysis: Unveiling a 36% Upside Potential in Biotech Innovation

Disc Medicine, Inc. (NASDAQ: IRON) is making waves in the biotechnology sector, attracting keen interest from investors with its innovative approach to hematologic disease treatment. With a market capitalization of..

Structure Therapeutics Inc. (GPCR) Stock Analysis: A Promising Biotech with a 115% Upside Potential

Structure Therapeutics Inc. (NASDAQ: GPCR), a biopharmaceutical company at the forefront of developing transformative therapies, presents an enticing proposition for investors looking to capitalize on the burgeoning healthcare sector. With..

Artivion, Inc. (AORT) Stock Analysis: Healthcare Innovator Poised for 60% Upside

Artivion, Inc. (NASDAQ: AORT), a dynamic player in the healthcare sector specializing in medical devices, is attracting investor interest with its promising outlook and robust product portfolio. With a market..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a 252.82% Potential Upside with Strong Buy Ratings

Investors eyeing the healthcare sector may want to turn their attention to Opko Health, Inc. (NASDAQ: OPK), a company that presents a compelling investment opportunity with its significant potential upside...

Azenta, Inc. (AZTA) Investor Outlook: Navigating a Challenging Landscape with Strategic Partnerships

Azenta, Inc. (NASDAQ: AZTA) stands at an intriguing crossroads, poised between growth opportunities and operational challenges. As a player in the healthcare sector’s Medical Instruments & Supplies industry, Azenta has..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Can 44.7% Revenue Growth Justify Its Sky-High Forward P/E?

For investors looking at the potential of Establishment Labs Holdings Inc (NASDAQ: ESTA), the healthcare company specializing in medical devices, particularly breast implants under the Motiva Implants brand, presents a..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Navigating Potential with a Strong 20.89% Return on Equity

For investors seeking opportunities in the healthcare sector, Pediatrix Medical Group, Inc. (NASDAQ: MD) presents a compelling, albeit complex, profile. With a market capitalization of $2.15 billion, Pediatrix is a..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: An Insightful Look at Potential 53% Upside

In the rapidly evolving biotechnology sector, Dyne Therapeutics, Inc. (NASDAQ: DYN) is emerging as a noteworthy contender. This clinical-stage company is focused on developing innovative therapeutics for neuromuscular diseases, leveraging..

BioLife Solutions, Inc. (BLFS) Investor Outlook: Navigating Growth with a 4.9% Upside Potential

BioLife Solutions, Inc. (BLFS), a key player in the healthcare sector, specifically in the medical instruments and supplies industry, is making waves with its innovative contributions to the cell and..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Evaluating a 26.74% Potential Upside Amidst Volatile Revenue Growth

PTC Therapeutics, Inc. (NASDAQ: PTCT) stands as a notable player in the biotechnology sector, primarily focused on rare disorders. With a market capitalization of $6.29 billion, this Warren, New Jersey-based..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 12% Potential Upside in Non-Opioid Pain Management

Pacira BioSciences, Inc. (NASDAQ: PCRX), a prominent player in the U.S. healthcare sector, is making waves with its innovative approach to non-opioid pain management solutions. With a market capitalization of..

Search

Funds

July 28, 2026

Search

Funds

July 28, 2026

FTSE 100

Funds